Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Aytu Bioscience Inc (NQ: AYTU)
0.8800 USD  UNCHANGED
Official Closing Price  /  Updated: 5:57 PM EST, Nov 20, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 176,100
Open 0.8900
Bid (Size) 0.8541 (8)
Ask (Size) 0.9290 (1)
Prev. Close 0.8800
Today's Range 0.8355 - 0.9180
52wk Range 0.2330 - 6.960
Shares Outstanding 35,883,069
Dividend Yield N/A
Performance
YTD
-61.90%
-61.90%
1 Month
-30.71%
-30.71%
3 Month
-80.05%
-80.05%
6 Month
+154.63%
+154.63%
1 Year
-70.47%
-70.47%
Top News
More News
Investor Expectations to Drive Momentum within ANGI Homeservices, Aytu Bioscience, IRIDEX, Cellular Biomedicine Group, CounterPath, and EXFO — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ANGI Homeservices Inc.... Read More
from GlobeNewswire News Releases
Aytu BioScience Announces Positive Interim Results from Natesto(R) Spermatogenesis Study
from ACCESSWIRE
More News
Read More
Aytu BioScience to Report Interim Results from Natesto(R) Spermatogenesis Study on Thursday, November 15, 2018
from ACCESSWIRE
Aytu BioScience Reports 55% Sequential Revenue Growth in Q1 FY19; Adds Tuzistra(R) XR to Portfolio
from ACCESSWIRE
Aytu BioScience Enters $3 Billion Cough and Cold Market and Expands Primary Care Portfolio, with Exclusive U.S. Licensing of Revenue-Generating, FDA-Approved Antitussive Tuzistra(R) XR
from ACCESSWIRE
Aytu BioScience to Report Fiscal First Quarter 2019 Results and Business Update
from ACCESSWIRE
Aytu BioScience Announces Issuance of First U.S. Patent Covering MiOXSYS(R) for Male Infertility; Company Progresses Toward U.S. Regulatory Clearance and Commercialization
from ACCESSWIRE
Aytu BioScience Announces Closing of $15.2 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
from ACCESSWIRE
Aytu BioScience Receives $5M Investment To Further Expansion Plans, Enter 'Cough And Cold' Market
category News , Tuzistra , Armistice Capital , and 6 more.
from Benzinga
Mid-Day Market Update: Dow Surges 125 Points; Inuvo Shares Spike Higher
category Commodities , Market News , Mid/Day Market Update , and 16 more.
from Benzinga
Mid-Morning Market Update: Markets Mostly Lower; SYSCO Misses Q1 Expectations
category WBT , Intraday Update , AYTU , and 16 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.